EXHIBIT 10.31 CONFIDENTIAL TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • October 24th, 2007 • Focus Media Holding LTD • Services-advertising agencies
TECHNOLOGY TRANSFER AGREEMENT This Agreement is entered into this 12 day of May, 2000 by and between Evan Gamble ("GAMBLE") and Molecular Robotics, Inc. ("MRI"). WHEREAS GAMBLE has developed certain useful technologies ("Technologies") as are listed...Technology Transfer Agreement • January 22nd, 2001 • Molecular Robotics Inc • Computer peripheral equipment, nec • California
AGREEMENTTechnology Transfer Agreement • April 5th, 2001 • Interglobal Waste Management Inc • California
CORAGE, LTD. TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • November 13th, 2002 • DSP Group Inc /De/ • Radio & tv broadcasting & communications equipment • Delaware
This Technology Transfer Agreement (this “Agreement”), effective as of November 1, 2002 (the “Effective Date”), is entered into by and between DSP Group Ltd. (“DSPGL”), an Israeli corporation, and Corage, Ltd. (“Corage”), an Israeli corporation and a wholly owned subsidiary of DSPGL.
Exhibit 10.3 Affymax/Maxygen Technology Transfer Agreement By and among Affymax Technologies N.V. and Glaxo Group Limited (collectively "the Glaxo Wellcome Companies"), and Maxygen, Inc. 1.0 INTRODUCTION 1.1 The parties to this Agreement are: Affymax...Technology Transfer Agreement • December 15th, 1999 • Maxygen Inc • Services-commercial physical & biological research • California
FIFTH AMENDMENT OF TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 11th, 2008 • InB:Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
THIS FIFTH AMENDMENT OF TECHNOLOGY TRANSFER AGREEMENT is made in Newark, Delaware, on the _17_day of December, 2007, between FRAUNHOFER USA, INC., acting through its Center for Molecular Biotechnology a Rhode Island non-profit corporation, having a place of business at 9 Innovation Way, Suite 200, Newark, Delaware 19711 ("Fraunhofer”); and INB:BIOTECHNOLOGIES INC., having a place of business at 9 Innovation Way, Suite 100, Newark, Delaware 19711 ("INB").
CEVA, INC. TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • November 13th, 2002 • DSP Group Inc /De/ • Radio & tv broadcasting & communications equipment • Delaware
This Technology Transfer Agreement (this “Agreement”), effective as of November 1, 2002 (the “Effective Date”), is entered into by and between DSP Group Inc. (“DSPGI”), a Delaware corporation, and Ceva, Inc. (“Ceva”), a Delaware corporation and a wholly owned subsidiary of DSPGI.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • June 14th, 2018 • Realm Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Technology Transfer Agreement (“Agreement”) is entered into as of April 4, 2018 (“Effective Date”) between Realm Therapeutics, Inc., a Delaware corporation (“RTI”) and Vitold M. Bakhir (“Licensor”) and sets forth the terms and conditions that will apply to the transfer of certain technology and the grant of certain licenses from Licensor to RTI.
AGREEMENT FOR TRANSFER OF TECHNOLOGYTechnology Transfer Agreement • August 7th, 2024
THIS AGREEMENT / MEMORANDUM OF UNDERSTANDING made and executed on this day of ……………………………………………………….BETWEEN KERALA AGRICULTURAL UNIVERSITY, having its registered office at VELLANIKKARA, THRISSUR 680 656 (hereinafter called as the ‘UNIVERSITY’) represented by its Registrar (which expression shall, where the context so admits include his successors and respective assigns) on the one part and …………………………………… (hereinafter called as the ‘CONTRACTING PARTY (which expression shall, where the context so admits include its / his successors / legal heirs and respective assigns) on the other part.
EXHIBIT 10.1 AGREEMENT FOR THE TRANSFER OF TECHNOLOGY Subscribed between EMBOTELLADORA "LA CASCADA LTDA.", represented by their general managers Mr. Jose Ezzidin Eid Montano with I.D. # 1479436 - SC and Ms. Angelina Torchio de Eid with I.D. # 1984600...Technology Transfer Agreement • April 28th, 1999 • Usa Sunrise Beverages Inc
Technology Transfer AgreementTechnology Transfer Agreement • December 24th, 2020
Whereas, Party B has developed, invented, and/or made the practical technology through utilizing resources and research facilities provided by Party A.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • July 12th, 2005 • Resin Systems Inc • Textile mill products • Alberta
This Technology Transfer Agreement made and dated January 6, 2003 is between RESIN SYSTEMS INC., an Alberta, Canada corporation (the “Vendor”) and RESIN SYSTEMS INTERNATIONAL LTD., a corporation incorporated under the laws of Barbados (the “Purchaser”).
EX-10.3 4 dex103.htm TECHNOLOGY TRANSFER AGREEMENT BY AND BETWEEN SHIJIAZHUANG PHARMACEUTICAL GROUPTechnology Transfer Agreement • May 5th, 2020 • Hong Kong
Portions of this Exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. Such omissions are designated as ***.
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • January 13th, 2009 • Micron Technology Inc • Semiconductors & related devices • Delaware
This TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), is made and entered into as of this 26th day of November, 2008 (“Effective Date”), by and among Nanya Technology Corporation Nanya Technology Corporation [Translation from Chinese] , a company incorporated under the laws of the Republic of China (“NTC”), Micron Technology, Inc, a Delaware corporation (“Micron”), and Inotera Memories, Inc., a company-limited-by-shares incorporated under the laws of the Republic of China (“Joint Venture Company”). (NTC, Micron and Joint Venture Company are referred to in this Agreement individually as a “Party” and collectively as the “Parties”).
ContractTechnology Transfer Agreement • January 26th, 2011 • Manhattan Scientifics Inc • Miscellaneous electrical machinery, equipment & supplies • New Mexico
The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 406 under the Securities Act of 1933, and Rule 24b-2, under the Securities Exchange Act of 1934, Redacted portions of this exhibit are marked by an ***.
AGREEMENTTechnology Transfer Agreement • February 7th, 2020 • New Jersey
This Agreement (hereinafter “Agreement”), made as of day of , 20 , by and between , (“Selling Company”), a company organized under the laws of the State of , having its
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • February 15th, 2005 • Infitech Ventures Inc • Petroleum refining
RECITALSTechnology Transfer Agreement • March 28th, 2003 • Parthusceva Inc • Semiconductors & related devices • Delaware
December 18, 2012Technology Transfer Agreement • April 29th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations
This letter agreement (this “Letter”) refers to the Technology Transfer Agreement dated December 18, 2012 (the “TTA”), between Regado Biosciences, Inc., a Delaware corporation (“Regado”) and Domain Russia Investments Limited, an English Limited Company (“DRI”), pursuant to which Regado has assigned certain Assigned IP and licensed certain Licensed IP to DRI in the Territory.
EXECUTION VERSION TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • May 5th, 2020 • New York
This Technology Transfer Agreement (this “Agreement”) is effective as of June 28, 2018 (the “Effective Date”), by and between Masthercell Global Inc., a Delaware corporation (“MTH Global”), and Orgenesis Inc., a Nevada corporation (including its Affiliates, “Orgenesis”). MTH Global and Orgenesis are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
A draft agreement has been submitted to the Children's Hospital of Philadelphia Office of Technology TransferTechnology Transfer Agreement • May 31st, 2016
NOTE BY THE DEPARTMENT OF STATETechnology Transfer Agreement • February 28th, 2012
therein contained, in all the courts of law and equity and of maritime jurisdiction, and in all the tribunals and public offices of the
Technology Transfer Agreement between Merck KGaA (“Merck”), Frankfurter Strasse 250, 64271 Darmstadt and Nitec Pharma AG (“Nitec Pharma”) Switzerland PreambleTechnology Transfer Agreement • October 21st, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations
Merck has been marketing corticoids (Fortecortin, Decortin, Decortin H, Solu Decortin H) successfully – primarily in Germany – for many years. In order to support the corticoid business Merck started developing Prednison Night Time Release in 1998, which is a novel galenic formulation using the active agent prednison. For the treatment of rheumatoid arthritis (“RA”) the Project (as defined hereinafter) has not yet entered phase 3 of clinical testing.
Technology Transfer Agreement By and Among Maxygen, Inc. Maxygen Holdings Ltd. Maxygen ApS and Bayer HealthCare LLC Dated July 1, 2008Technology Transfer Agreement • January 9th, 2009 • Maxygen Inc • Services-commercial physical & biological research • New York
This Technology Transfer Agreement (this “Agreement”) is made and entered into on this 1st day of July 2008 (the “Execution Date”), by and between Maxygen, Inc. (“Maxygen”), a Delaware corporation, Maxygen Holdings Ltd. (“Holdings”), a wholly owned subsidiary of Maxygen and a company organized under the laws of the Cayman Islands, Maxygen ApS, a wholly owned subsidiary of Holdings and a company organized under the laws of the Kingdom of Denmark (“ApS”), and Bayer HealthCare LLC (“Bayer”), a Delaware limited liability company.
EX-10.24 23 d316941dex1024.htm TECHNOLOGY TRANSFER AGREEMENT TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER AGREEMENT (THIS “Agreement”) IS ENTERED INTO AS OF THIS 29TH DAY OF FEBRUARY, 2012, BY AND BETWEEN: The Proprietor and the Recipient...Technology Transfer Agreement • May 5th, 2020 • California
WHEREAS, the Proprietor has developed LCDTV 8CH + Boost LED BLU Driver and LCDTV TCON Bias PMIC products, the details of which are set forth on Schedule 1 attached hereto (the “Target Products”) and is the proprietor of certain know-how and confidential information relating to their designs, applications and/or manufacture;
Executory Contracts And Unexpired Leases To Be RejectedTechnology Transfer Agreement • July 31st, 2009
EXHIBIT 10.1(a) AGREEMENTTechnology Transfer Agreement • August 14th, 1998 • Alaris Medical Systems Inc • Surgical & medical instruments & apparatus
TECHNOLOGY TRANSFER AGREEMENT Dated December 18, 2012 By and Between DOMAIN RUSSIA INVESTMENTS LIMITED And REGADO BIOSCIENCES, INC.Technology Transfer Agreement • April 29th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New York
THIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is dated as of December 18, 2012 (the “Effective Date”), by and between Domain Russia Investments Limited, a private limited company incorporated and existing under the laws of England and Wales with registration number 7899075, having its registered office at c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KYI-1104, Cayman Islands (“DRI” or “Transferee”), and Regado Biosciences, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 318 Blackwell Street, Suite 130 Durham, North Carolina, 27701 USA (“Company”). DRI and the Company may each be referred to herein as a “Party” or, collectively, as “Parties.”
EX-10.6 10 a2220119zex-10_6.htm EX-10.6 THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS MARKED WITH [XXXXXXXXX] AND HAS BEEN...Technology Transfer Agreement • May 5th, 2020 • New York
THIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is dated as of 4 December 2012 (the “Effective Date”), by and between Domain Russia Investments Limited, a private limited company incorporated and existing under the laws of England and Wales with registration number 7899075, having its registered office at The Broadgate Tower, Third Floor, 20 Primrose Street, City of London, EC2A 2RS, United Kingdom (“DRI”), and Marinus Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 21 Business Park Drive, Branford, Connecticut 06405, USA (“Company”). DRI and Company may each be referred to herein as a “Party” or, collectively, as “Parties.”
TECHNOLOGY TRANSFER AGREEMENTTechnology Transfer Agreement • December 2nd, 2017
[2] (hereinafter referred to as the "Transferor"), a company duly incorporated and existing under the laws of [3] and [4] (hereinafter referred to as "Transferee"), a company duly incorporated and existing under the laws of [5].
RECITALSTechnology Transfer Agreement • March 3rd, 1999 • Aps Holding Corporation • Wholesale-motor vehicle supplies & new parts • Delaware
TECHNOLOGY TRANSFER AGREEMENT Between ..........management LIMITED And .......... Vietnam co., ltd PREAMBLETechnology Transfer Agreement • August 21st, 2015
This Technology Transfer Agreement (hereinafter referred to as the “Agreement”) is entered into on this [] day of [ ]2005 by and between:
ContractTechnology Transfer Agreement • February 17th, 2005
RECITALSTechnology Transfer Agreement • October 1st, 2002 • Iwizard Holding Inc • Arizona
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION BOTH IS NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED ** Technology Transfer AgreementTechnology Transfer Agreement • October 9th, 2020 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations • Hong Kong
This Technology Transfer Agreement between Qualigen, Inc. (“Qualigen”), a legal entity incorporated in Delaware, USA, with its offices at 2042 Corte del Nogal, Suite B, Carlsbad, California 92011, USA; and Yi Xin Zhen Duan Jishu (Suzhou) Ltd. (翊新诊断技术（苏州）有限公司) (“Licensee”), a legal entity registered in Room 301, 302, Building 9, No. 188 Fu Chung Jiang Lu, Suzhou High Technology Zone, Suzhou,（中国苏州富春江路188号9号楼301，302室）, the People’s Republic of China (individually “Party” and together “Parties”), is effective as of October 7, 2020 (“Effective Date”).
